The annualized week 73 SUVR changes and the LMEM SUVR slopes were similar across target regions, but both measurements were numerically lower than the annualized week 49 SUVR change, particularly in the mild AD group or the mid- to high-tau groups. This evidence concerns the gene MAPT and Alzheimer disease.